12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Company News  |  Other News

Forest Laboratories generics, pharmaceuticals news

Forest and activist investor Carl Icahn issued dueling SEC filings last week arguing in favor of their respective director slates ahead of the company's Aug. 18 annual meeting. Icahn said his proposed slate of four directors - Alexander Denner, Richard...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >